Skip to main content

Table 4 Drug treatment prescribed at baseline (after change) by class

From: The management of bipolar mania: a national survey of baseline data from the EMBLEM study in Italy

Monotherapy (n = 137) Co-therapy with 2 drugs (n = 264) Polytherapy (> 2 drugs) (n = 151)
Drug N (%) Drugs N (%) Drugs N (%)
Olanzapine 69 (50.4) Olanzapine/Valproate 59 (22.3) Olanzapine/Valproate/Lithium 11 (7.3)
Valproate 21 (15.3) Olanzapine/Lithium 39 (14.8) Olanzapine/other AC/Lithium 10 (6.6)
Risperidone 11 (8.0) Olanzapine/non-valproate AC 34 (12.9) Olanzapine/other typicals/Valproate 8 (5.3)
Other AC 10 (7.3) Risperidone/Valproate 19 (7.2) Olanzapine/other typicals/other AC 7 (4.6)
Lithium 9 (6.6) Other typical/atypical 16 (6.1) Olanzapine/other typicals/lithium 2 (1.3)
Quetiapine 6 (4.4) Risperidone/Lithium 14 (5.3) Other combinations 113 (74.8)
Haloperidol 6 (4.4) Other atypical/Valproate 11 (4.2)   
Other typical 4 (2.9) Haloperidol/Lithium 9 (3.4)   
Other atypical 1 (0.7) Other atypical/non-valproate AC 7 (2.7)   
   Other typical/Lithium 7 (2.7)   
   2 typicals 7 (2.7)   
   Other typical/non-valproate AC 6 (2.3)   
   Risperidone/non-valproate AC 6 (2.3)   
   Other combinations 30 (11.4)   
  1. AC = Anticonvulsivants;